ALHC · Insider Trading
Alignment Healthcare, Inc. Common Stock
Every open-market purchase and sale reported by ALHC officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Form 4 Filings
50
most recent
Open-Market Buys
1
code P
Sales
29
code S
Reporting Insiders
25
current holders
ALHC — Recent Form 4 Transactions (latest 2026-10-07)
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-07 | Hyong Kim | Chief Medical Officer | Sell | −32,479 | −$269.58K |
| 2026-09-18 | Joseph S Konowiecki | EVP, Corporate Affairs | Sell | −23,511 | −$202.43K |
| 2026-09-16 | John E Kao | Chief Executive Officer | Sell | −27,400 | −$356.20K |
| 2026-09-11 | Dawn Christine Maroney | President | Sell | −122,707 | −$1.56M |
| 2026-09-11 | John E Kao | Chief Executive Officer | Sell | −557,870 | −$7.12M |
| 2026-08-18 | Dawn Christine Maroney | President | Sell | −5,000 | −$70.00K |
| 2026-08-10 | John E Kao | Chief Executive Officer | Sell | −298,000 | −$4.14M |
| 2026-07-16 | Dawn Christine Maroney | President | MIXED | −25,000 | −$2.31M |
| 2026-07-14 | John E Kao | Chief Executive Officer | Sell | −298,000 | −$5.92M |
| 2026-07-02 | Shane J. Hochradel | Chief Operations Officer | A | +87,719 | — |
| 2026-07-01 | Joseph S Konowiecki | EVP, Corporate Affairs | Sell | −25,000 | −$600.00K |
| 2026-06-26 | Joseph S Konowiecki | EVP, Corporate Affairs | Sell | −25,000 | −$575.00K |
| 2026-06-18 | Joseph S Konowiecki | EVP, Corporate Affairs | Sell | −25,000 | −$550.00K |
| 2026-06-15 | Dawn Christine Maroney | President | Sell | −30,000 | −$586.42K |
| 2026-06-15 | Hyong Kim | Chief Medical Officer | Sell | −35,951 | −$713.95K |
| 2026-06-12 | Joseph S Konowiecki | EVP, Corporate Affairs | Sell | −25,000 | −$525.00K |
| 2026-06-12 | John E Kao | Chief Executive Officer | Sell | −298,000 | −$6.07M |
| 2026-06-09 | Joseph S Konowiecki | EVP, Corporate Affairs | A | +122,807 | — |
| 2026-06-09 | Mark D. Kent | President - MSO | A | +87,719 | — |
| 2026-06-02 | Mark D. Kent | President - MSO | Buy | +14,848 | +$197.63K |
| 2026-05-19 | Dawn Christine Maroney | President | MIXED | −51,500 | −$482.56K |
| 2026-05-13 | John E Kao | Chief Executive Officer | Sell | −298,000 | −$5.03M |
| 2026-04-15 | Dawn Christine Maroney | President | Sell | −30,000 | −$626.20K |
| 2026-04-13 | John E Kao | Chief Executive Officer | Sell | −298,000 | −$6.16M |
| 2026-04-08 | James M Head | Chief Financial Officer | Sell | −11,100 | −$233.99K |
| 2026-04-08 | John E Kao | Chief Executive Officer | Sell | −250,000 | −$5.25M |
| 2026-04-01 | Christopher J Joyce | Chief Legal and Admin. Officer | Sell | −18,013 | −$320.49K |
| 2026-03-23 | John E Kao | Chief Executive Officer | Sell | −118,000 | −$2.06M |
| 2026-03-19 | Christopher J Joyce | Chief Legal and Admin. Officer | Sell | −25,125 | −$448.23K |
| 2026-03-19 | Dawn Christine Maroney | President | Sell | −36,749 | −$655.60K |
| 2026-03-19 | Sebastian Burzacchi | COO - Mgmt Services Org | Sell | −15,361 | −$274.04K |
| 2026-03-19 | Andreas P. Wagner | Chief Human Resources Officer | Sell | −23,602 | −$425.48K |
| 2026-03-19 | John E Kao | Chief Executive Officer | Sell | −73,046 | −$1.30M |
| 2026-03-19 | Hyong Kim | Chief Medical Officer | Sell | −18,404 | −$328.33K |
| 2026-03-19 | Robert L. Scavo | Chief Information Officer | Sell | −11,285 | −$201.32K |
| 2026-03-17 | Sebastian Burzacchi | COO - Mgmt Services Org | A | +36,198 | — |
| 2026-03-17 | Joseph S Konowiecki | Director | A | +24,868 | — |
| 2026-03-17 | Andreas P. Wagner | Chief Human Resources Officer | A | +23,543 | — |
| 2026-03-17 | Jody L Bilney | Director | A | +16,039 | — |
| 2026-03-17 | Jacqueline B Kosecoff | Director | A | +13,096 | — |
| 2026-03-17 | Adnan R. Mansour | Chief Digital Officer | A | +25,015 | — |
| 2026-03-17 | Margaret M McCarthy | Director | A | +14,273 | — |
| 2026-03-17 | David C Hodgson | Director | A | +18,982 | — |
| 2026-03-17 | Hyong Kim | Chief Medical Officer | A | +52,972 | — |
| 2026-03-17 | Christopher J Joyce | Chief Legal and Admin. Officer | A | +51,501 | — |
| 2026-03-17 | Yon Jorden | Director | A | +13,096 | — |
| 2026-03-17 | John E Kao | Chief Executive Officer | A | +338,434 | — |
| 2026-03-17 | Dawn Christine Maroney | President | MIXED | +131,860 | −$524.43K |
| 2026-03-17 | Nicholas Robbert Vorhoff | Director | A | +18,982 | — |
| 2026-03-17 | James M Head | Chief Financial Officer | A | +103,002 | — |
ALHC — Current Insider Holders
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| GAP COINVESTMENTS IV, LLC | Director | 61,302,175 | $431.87M |
| General Atlantic (SPV) GP, LLC | Director | 30,842,175 | $217.28M |
| General Atlantic Partners 95, L.P. | Director | 24,596,079 | $173.28M |
| GAP Coinvestments CDA, L.P. | Director | 13,476,585 | $94.94M |
| General Atlantic (ALN HLTH), L.P. | Director | 13,476,585 | $94.94M |
| John E Kao | Chief Executive Officer | 1,814,239 | $12.78M |
| Robert Thomas Freeman | Chief Financial Officer | 1,557,348 | $10.97M |
| Joseph S Konowiecki | EVP, Corporate Affairs | 1,080,305 | $7.61M |
| Dawn Christine Maroney | President | 794,606 | $5.60M |
| Hakan Kardes | Chief Experience Officer | 678,987 | $4.78M |
| Robert L. Scavo | Chief Information Officer | 487,685 | $3.44M |
| Mark B. McClellan | Director | 370,531 | $2.61M |
| Christopher J Joyce | Chief Legal and Admin. Officer | 305,451 | $2.15M |
| Jacqueline B Kosecoff | Director | 303,963 | $2.14M |
| Hyong Kim | Chief Medical Officer | 299,271 | $2.11M |
| Sebastian Burzacchi | COO - Mgmt Services Org | 258,630 | $1.82M |
| James M Head | Chief Financial Officer | 173,495 | $1.22M |
| David C Hodgson | Director | 173,408 | $1.22M |
| Nicholas Robbert Vorhoff | Director | 173,408 | $1.22M |
| Andreas P. Wagner | Chief Human Resources Officer | 160,230 | $1.13M |
| Margaret M McCarthy | Director | 144,441 | $1.02M |
| Jody L Bilney | Director | 129,267 | $910.69K |
| Yon Jorden | Director | 105,830 | $745.57K |
| Mark D. Kent | President - MSO | 102,567 | $722.58K |
| Shane J. Hochradel | Chief Operations Officer | 87,719 | $617.98K |
ALHC Insider Trading FAQ
Who are the insiders at ALHC?
25 officers, directors and 10%+ beneficial owners currently report holdings in ALHC via SEC Form 4.
Are ALHC insiders buying or selling?
Across the 50 most recent Form 4 filings for ALHC, 1 were open-market purchases (code P) and 29 were sales (code S). Sales frequently reflect scheduled 10b5-1 plans or tax withholding rather than a view on the stock.
How current is ALHC insider data?
Form 4 must be filed within two business days of the transaction, so this is close to real time. The most recent ALHC filing is dated 2026-10-07.
How to read Form 4 activity
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the ALHC quote page; the site-wide leaderboard is on the insider transactions hub.
More on ALHC
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.